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Background: Metastasis is a process where only a small subset of cells is capable of successfully migrating to and
propagating at secondary sites. TGF-β signalling is widely known for its role in cancer metastasis and is associated
with cell migration in whole cell populations.
Findings: We extend these findings by investigating the role of TGF-β signalling in promoting migration and
motility by imaging the signalling activity in live, individual MDA-MB-231 cancer cells utilizing a novel Smad3
Td-Tomato reporter adenovirus. Here we find that not all MDA-MB-231 cancer cells have similar TGF-β mediated
Smad3 transcription activity and display at least two distinct migratory populations. Importantly, Smad3 activity was
significantly higher within migratory cells compared to non-migrated cells in wound healing and transwell assays.
Furthermore, time-lapse experiments showed that MDA-MB-231 cells displaying Smad3 activity moved faster and a
greater distance compared to cells not displaying Smad3 reporter activity. Interestingly, despite being more motile
than cells with undetectable levels of Smad3 activity, high Smad3 activity was detrimental to cell motility compared
to low and medium level of Smad3 activity.
Conclusions: We have developed a method enabling real-time visualization of TGF-β signalling in single live cells.
Breast cancer cell motility and migration is driven by sub-populations of cells with dynamic TGF-β-Smad3 activity.
Those sub-populations may be responsible for tumor invasion and metastasis.
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Tumour metastasis is a multistep process with each
phase presenting physical, biological and immune chal-
lenges that must be overcome by metastatic capable
tumour cells to achieve successful propagation of the
secondary site [1,2]. Subsequently, only a very small per-
centage of tumour cells successfully metastasize [3]. How-
ever, the critical molecular differences between this small
subset of cells compared to their non-metastatic neighbors
within the same tumour population have not been fully
established. Furthermore, clinical evaluation of metastasis* Correspondence: hongjian@unimelb.edu.au
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unless otherwise stated.generates overall genomic and proteomic differences be-
tween primary versus secondary tumours following meta-
static completion and thus does not assess the dynamic
changes during each stage of metastasis [4-6]. Successful
movement through each stage of metastasis is dependent
upon tumour cells possessing a favorable pro-metastatic
signalling signature and is paramount upon appropriate
timing of activity of these signalling networks, where
activity may be critical for one phase but inhibitory for
another.
Transforming Growth Factor-β (TGF-β) regulates a
plethora of cellular processes including promotion of
cancer invasion and metastasis [7-10]. Many studies
have shown that TGF-β increases pro-invasive factors,
enhances migration and invasion in culture [11-14] andThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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these observations have been made by assessing the
effect of TGF-β across the global, overall tumour popu-
lation. We expand on these findings in this current study
to determine the effect of real-time TGF-β signalling
while tracking live single cell movement.
Results and discussion
Cells with increased TGF-β signalling activity exhibit
enhanced wound healing
Time-lapse microscopy studies showed that MDA-MB-231
cells (human breast carcinoma cell line) moved an overall


























































Figure 1 Live single cell TGF-β signalling promotes wound healing. A
then tracked for 10 h with images taken every 4 min. Slow moving cells (iii) a
TGF-β. B. MDA-MB-231 cells were infected with Ad.Cre-GFP and Ad.CAGA-Td-
C. MDA-MB-231 cells were infected with Ad.CMV-Td-Tom at varying MOI or D
with ± TGF-β (5 ng/ml) for 24 h, cells were fixed, permeabilised and stained w
expression (Red) compared to nuclear staining (blue). E. Wound Area at 0 and
virus and stimulated with ± TGF-β (5 ng/ml). F. 24 h post wound, cells were fi
visualizing Smad3 active cells (red) and nuclear staining (blue). 42% (360 out o
cells in the wounded area. G. The relative pixel intensity of Smad3 activity wa
representative of at least 3 separate experiments (*P < 0.05).compared to without (Figure 1A(i)). Intriguingly, we ob-
served two distinctive motility patterns within the whole
population of cells stimulated with TGF-β, less motile cells
(Figure 1A(iii)) and more motile cells (Figure 1A(iv)). This
result was seen consistently across at least 3 separate
experiments. This led us to determine if individual cells
displayed varied TGF-β-driven Smad3 activity within the
same population. This was achieved by engineering an
adenoviral Smad3-Td-Tomato reporter (Ad.CAGA-Td-
Tom) that yields Td-Tomato fluorescence intensity dir-
ectly proportional to the level of Smad3 transcriptional
activity. Td-tomato expression increased as expected in both



































. MDA-MB-231 cells were treated without (i) or with (ii) TGF-β (5 ng/ml)
nd fast moving cells (iv) within the same cell population treated with
Tom virus, stimulated with TGF-β and imaged for both GFP and Td-Tom.
. Ad.CAGA-Td-Tom virus at a MOI of 2500. Following stimulation
ith DAPI. Percentage positivity was calculated by visualising Tomato
24 h post wound after cells had been infected with Ad.CAGA-Td-Tom
xed, permeabilised and nuclear stained as above and images were taken
f 867) cells were positive in the non-wound area versus 62% (175/279)
s quantified (Average of 5 randomly chosen fields ± SD). These data are
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similarly to that expected with Smad3 activity. Import-
antly, our adenovirus did not change any observable
properties of TGF-β stimulation, as cells infected with
the Ad-CAGA-Td-Tom virus still observed expected,
well established outcomes of TGF-β-driven Smad2/3
activity including enhanced Smad2 nuclear localisation
despite Adenoviral infection (Additional file 1: Figure 1D).
To determine whether our adenovirus could be infected
into every cell, cells were co-infected with Ad-Cre-
GFP and Ad.CAGA-Td-Tom prior to TGF-β stimulation
(Figure 1B). Every cell was infected as evident by all cells
showing detectable GFP, while Td-Tomato was only de-
tected in TGF-β-responsive cells. To further confirm that
our adenovirus was entering every cell (and therefore is a
true indication of Smad3 activity within every cell), we
used a Multiplicity of Infection (MOI) that produced
Td-Tomato expression in 100% of MDA-MB-231 cells
when driven by a CMV promoter (Ad.CMV-Td-Tom)
(Figure 1C). At this MOI (2500), we observed that
approximately 36% of MDA-MB-231 cells displayed
detectable Smad3 transcriptional activity after 24 h of
TGF-β stimulation, compared to 0% without TGF-β
(Figure 1D). We have consistently seen a plateau of ap-
proximately 40% of TGF-β/Smad3 driven td-Tomato
positive cells across a range of MOI’s (Additional file 2:
Figure S2). Likewise, Td-Tomato expression driven by
the CMV promoter was observed in 100% of U87MG
human glioblastoma cells at an MOI of 2500 (Additional
file 3: Figure S3A). At this MOI, approximately 5% of
U87MG cells displayed detectable Smad3 reporter activity
after infection of the Ad.CAGA-Td-Tom virus (Additional
file 3: Figure S3B). These results are consistent with pre-
vious reports where Smad3 phosphorylation is often
observed in heterogeneous patterns throughout clinical
or mouse tumour sections indicating that not all cells
within a tumour are uniformally active for TGF-β-Smad
signalling at any one time [13,18-21].
We next infected MDA-MB-231 cells with the Ad.
CAGA-Td-Tom adenovirus in a wound healing assay.
TGF-β could clearly accelerate the overall movement of
MDA-MB-231 cells into the wound area (Figure 1E) and
significantly enhanced Smad3 activity in cells within and
outside the wound area compared to unstimulated cells
(Figure 1F). Importantly, we found that a significantly
greater percentage of cells (62 ± 6%) in the wound area
displayed Smad3 activity compared to the non-wound
area (42 ± 7%) after TGF-β stimulation (Figure 1F). Fur-
thermore, the relative pixel intensity of Smad3 activity
per cell in the wound area was also significantly 2-fold
higher compared to the intensity in cells from the non-
wound area (Figure 1G). A greater percentage of Smad3
active cells were seen in the wound area (14.9%) com-
pared to the non-wound area (4%) in the U87MG cellline also (Additional file 3: Figure S3C). These results
indicate that TGF-β-induced Smad3 activity is more
prevalent in cells that are capable of “closing” the wound
and may suggest that Smad3-active cells are more motile
compared to their non-Smad3 active counterparts within
the same MDA-MB-231 population.
Cells with increased TGF-β signalling activity exhibit
enhanced cell migration
Similarly to wound healing, TGF-β stimulation promotes
cell migration and invasion [14,22]. To confirm these
findings in our system and examine Smad3 activity in
migrating cells we co-infected MDA-MB-231 cells with
the Smad3-driven and CMV-driven luciferase adenovi-
ruses, Ad.CAGA-Fluc and Ad.CMV-Gluc and performed
transwell migration assays. As non-migrated cells are
difficult to collect we seeded cells into a 96-well plate as
a model for non-migratory cells. Direct assessment of
cell number revealed that TGF-β enhanced transwell mi-
gration approximately 4-fold compared to cells without
TGF-β stimulation (Figure 2A). Furthermore Smad3 ac-
tivity in migratory cells was significantly 2-fold greater
compared to non-migratory cells (Figure 2B). However,
these results only measure the average TGF-β-Smad3
signalling activity across the global cell population.
Therefore to determine whether this overall TGF-β-
mediated pro-migratory response was due to specific mi-
gratory cells displaying greater TGF-β signalling activity,
we infected MDA-MB-231 cells with our Ad.CAGA-Td-
Tom adenovirus and performed transwell assays. As
above, cells were seeded into a tissue culture plate as a
model for non-migratory cells. Indeed, we found that a
significantly greater percentage of cells (72 ± 9%) that had
migrated through the transwell membrane displayed
Smad3 activity compared to the non-migrating cells (47 ±
6%) after TGF-β stimulation (Figure 3A). Furthermore,
the relative pixel intensity of Smad3 activity per cell in the
migratory cells was significantly 2-fold higher compared
to the intensity seen in cells from the non-migratory sub-
group (Figure 3B). These results suggest that TGF-β
signalling may be switched on during cell migration. Our
data is consistent with a previous report by Giampieri and
colleagues who showed that transient activation of TGF-
β-Smad3 signalling was present in single metastatic cells
moving from the primary site. Interestingly, they showed
that lung colonisation required down-regulation of TGF-β
signalling therefore suggesting that TGF-β signalling activ-
ity within metastatic capable cells must fluctuate from
high to low for successful metastasis [15].
Cells with increased TGF-β signalling activity exhibit
enhanced cell movement
We next determined whether active TGF-β-Smad3 signal-
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Figure 3 Live cell TGF-β signalling promotes cell migration.
MDA-MB-231 cells were infected with Ad.CAGA-Td-Tom virus and
stimulated with ± TGF-β (5 ng/ml) before being seeded in the apical
chamber of transwells and a 24-well plate in triplicate for 48 h. Cells
on the underneath of the transwell membrane and in the 24-well
plate were fixed, permeabilised and stained with DAPI. A. Images
were taken of the cells underneath the membrane (migrated cells)
and the 24-well plate (non-migrated cells) using a fluorescent
microscope visualizing Smad3 active cells (red) and nuclear staining
(blue). These data are representative of 3 separate experiments. B.
The relative pixel intensity of Smad3 activity was quantified using
imageJ software and presented as the average of 3 randomly

















































Figure 2 TGF-β signalling promotes cell migration. MDA-MB-231
cells were infected with Ad.CAGA-Fluc and Ad.CMV-Gluc virus then
stimulated with ± TGF-β (5 ng/ml) before being seeded onto the
apical chamber of transwells and a 96-well plate in triplicate for
48 h. Cells on the underneath of the transwell membrane and in the
96-well plate were lysed. A. The number of migrated cells through
the transwell membrane was calculated as described in the Materials
and Methods (Average ± SD). These data are representative of 3
separate experiments (*P < 0.05). B. Lysates were then assessed for
Smad3 luciferase activity per cell with TGF-β stimulation (■) or
without (□) and normalized with CMV-driven Gluc activity (Average ± SD).
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microscopy after infection with the Ad.CAGA-Td-Tom
adenovirus and TGF-β stimulation. As observed in
Figure 1, TGF-β-induced Smad3-driven Td-Tomato
expression in some, but not all cells. Importantly,
cells with detectable Smad3 activity moved a greater
average distance (Figure 4A(ii)) compared to those
that did not (Figure 4A(i)). In addition, Smad3 active
cells moved significantly faster (um/min) compared to
non-active cells (Figure 4B). Interestingly, the average
rate of movement was highest in the cells expressing
low and medium intensity Smad3 reporter activity
followed by cells expressing high intensity (Figure 4C).
A recent study found that cells that were heterozygous for
Smad3 were more invasive then wild-type cells and a
Smad3+/− mouse contained significantly greater incidenceof metastasis than wild-type mice [13]. Although Smad3
activity was not correlated to Smad3 allele number, these
and our results indicate that an intermediate level of
TGF-β signalling may be more favourable for tumour
cell motility and metastasis compared to higher Smad3
activity. Our current data identifies increased TGF-β-
driven Smad3 activity specifically in the subset of cells
which migrate and are more motile within the overall
population. It is predicted that these cells are the most
likely to metastasis in a biological system and thus our
findings are significant as understanding the key signal-
ling events in the metastatic capable cells allows for a
greater understanding in how to inhibit these cells. At-
tempts to target specific signalling molecules within live
cells with greater metastatic potential may provide cancer
patients with enhanced therapeutic benefit compared to
the clinical outcomes currently achieved.
Conclusions
TGF-β is only one critical pro-migratory signalling net-
work with combinational signals from other pathways











































































Figure 4 TGF-β Signalling within live individual tumour cells promotes cell motility. A. MDA-MB-231 cells were infected with Ad.CAGA-Td-
Tom virus and stimulated with ± TGF-β (5 ng/ml). 24 h later, cells were tracked for 10 h and imaged every 4 min. Images were quantified with the use
of Metamorph software, to track the distance moved by individual cells with (i) undetectable Smad3 activity and (ii) Smad3 activity following infection
with Ad.CAGA-Td-Tom virus and TGF-β stimulation (n = 10). B. Average Speed (um/min) of each group of 10 cells (*P < 0.05). C. Cells displaying Smad3
activity were divided into 3 categories based on the intensity (low, medium and high) of Smad3 activity. Data represent the average distance travelled
over time from each group (n = 7).
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viral reporter system provides proof-of-principle evi-
dence that the duration and intensity of signalling
molecules/pathways can be examined in individual cells
corresponding to cell behavior and may be achieved
examining two or more signalling pathways within the
one cell population. Importantly, our system may allow
in vivo examination of a signalling pathway of interest
such as the TGF-β network through each dynamic step
of metastasis specifically focusing on the critical small
subset of metastatic capable cells.
Methods
Cell lines and cell culture
The human malignant breast carcinoma cell line, MDA-
MB-231 and the human glioblastoma cell line U87MG
were purchased from ATCC (American Type Culture
Collection) and were maintained in DME medium con-
taining 10% heat inactivated foetal bovine serum, 2 mM
glutamine, 100 μg/ml penicillin and 100 μg/ml strep-
tomycin. Cells were incubated in 10% CO2 at 37°C in a
humidified incubator. All experiments were performed
in DME media containing 10% foetal bovine serum.
Immunofluorescence staining and confocal microscopy
MDA-MB-231 cells were seeded onto coverslips in 6-
well plates and allowed to adhere overnight. Cells werestimulated with or without TGF-β for 15 min. Cells were
then washed twice in PBS, fixed in formaldehyde and
permeabilized with PBS containing 0.2% Triton-X-100.
Following blocking in PBS-Tween20 containing 5% BSA,
cells were stained with anti-Smad2 antibody. Visuali-
sation was achieved with Alexa488-conjugated secondary
antibody using confocal microscopy as described [21,23].
Generation of the Ad-CAGA-Td-Tom Smad3 reporter and
CMV-driven Td-Tom adenoviruses
The pCAGA12-luc DNA which specifically measures
Smad3 activity [24] was first cloned into the pENTR 1A
entry clone vector (Invitrogen) to generate pENTR-
CAGA-luc as previously described [25]. The td-Tomato
gene from pCMV-Td-Tom (clonetech) was PCR ampli-
fied using forward primers containing EcoRI and HindIII
restriction sites and reverse primers containing EcoRI
and XbaI restriction sites and cloned into pENTR 1A
(Invitrogen) to yield pENTR-Td-Tom. Subsequent clon-
ing of the td-Tomato gene into pENTR-CAGA-luc using
restriction enzymes HindIII and XbaI was then perfor-
med such that the luciferase gene was removed, yielding
pENTR-CAGA-Td-Tom. LR recombination was then
performed with the pAd/PL-DEST Destination vector
(Invitrogen) to generate the pAd-CAGA12-Td-Tom Adeno-
viral plasmid. The plasmid was digested with Pac I and
then transfected into the adenovirus producing 293A cell
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(Invitrogen). Cells were harvested approximately 2 weeks
after transfection when lysis was observed in the majority
of cells. The adenovirus was amplified, titred and used to
detect TGF-β responses and Smad3 activity. Similarly,
Td-Tomato was cloned from pENTR-Td-Tom into the
pAd/CMV/V5-DEST Destination vector (Invitrogen)
using EcoRI restriction enzymes to generate the pAd.
CMV-Td-Tom Adenoviral plasmid. The pAd.CMV-Td-
Tom adenovirus was then produced and amplified as
outlined above.Multiplicity of infection (MOI) experiment
MDA-MB-231 and U87MG cells were seeded on to a 12
well tissue culture plate and infected with either Ad.
pCMV-td-tomato virus or Ad.pCAGA-td-tomato virus at
varying MOI (0, 200, 500, 2500 and 5000) and stimu-
lated with or without TGFβ1 (5 ng/ml). After 48 h the
cells were washed with PBS, fixed by adding 3.7% for-
maldehyde (Sigma-Aldrich, NSW, Australia) for 10 min
and permeabilised by adding 0.2% Triton X-100 in PBS.
A nuclear stain was performed by adding DAPI (1.5 μg/ml)
for 10 min and washed with PBS followed by a DDW
wash. The cells were then imaged using a fluorescent
microscope. A minimum of 100 cells were counted to cal-
culate the percentage of tomato positive cells (driven by
CMV and CAGA) and the intensity of both CMV and
CAGA driven tomato expression was determined using
image J software.Wound healing assay
Cells were infected with Ad.pCAGA-td-tomato virus at
an MOI of 2500 and seeded on to a 6 well tissue culture
plate. 24 h later cells were stimulated with or without
TGFβ1 (5 ng/ml). 48 h after seeding the cells, an in vitro
wound was produced by scratching the cell monolayer
using a sterile 200 μl pipette tip, the media was aspirated
and new media with or without TGF-β (5 ng/ml) was
added. The plates were left in a 37°C incubator for
5 min and imaged using a phase contrast microscope.
24 h after the scratch, the same fields were imaged. The
cells were washed with PBS and fixed by adding 3.7%
formaldehyde for 10 min and permeabilised by adding
0.2% Triton X-100 in PBS. A nuclear stain was perfor-
med by adding DAPI (1.5 μg/ml) for 10 min and washed
with PBS followed by a DDW wash. The cells were then
imaged using a fluorescent microscope. The images
were quantified using image J software where the
total amount of cells and the amount of cells express-
ing CAGA driven tomato expression (CAGA tomato
reporter activity) in the wound area and non-wound
area were counted. The intensity of the CAGA tomato re-
porter activity was also calculated using Image J software.Transwell tomato assay
The basal chamber of the transwell was pre-treated with
or without TGFβ1 (5 ng/ml) for 1 h. Cells were infected
with Ad.pCAGA-td-tomato virus at a MOI of 2,500 and
treated with or without TGF-β (5 ng/ml). 25,000 cells/
well were seeded in to the apical chamber of the trans-
well and in to a 24 well plate in triplicate. Following
48 h incubation, cells on the top surface of the mem-
brane were wiped off with cotton buds dipped in PBS
and discarded. The cells in the 24 well plate and the bot-
tom surface of the membrane were washed with PBS
and fixed by adding 3.7% formaldehyde for 10 min and
permeabilised by adding 0.2% Triton X-100 in PBS. A
nuclear stain was performed by adding DAPI (1.5 μg/ml)
for 10 min and washed with PBS followed by a DDW
wash. Cells were then imaged using a fluorescent micro-
scope and the percentage of CAGA tomato reporter
active cells and the intensity of the CAGA tomato re-
porter activity was measured using Image J software.
Transwell luciferase assay
The basal chamber of the transwell was pretreated with
or without TGFβ1 (5 ng/ml) for 1 h. Cells were infected
with Ad.pCAGA-td-luciferase virus and Ad.Gaussia-td-
luciferase virus at a MOI of 2500 and treated with or
without TGF-β (5 ng/ml). 25,000 cells/well were seeded
in to the apical chamber of the transwell in triplicate
and 2,500 cells were seeded in to a 96 well plate in tripli-
cate. Following 48 h incubation, cells on the top surface
of the membrane were wiped off with cotton buds
dipped in PBS and discarded. The membranes were
peeled off the insert and placed in empty wells. Cells
were then lysed and assessed for luciferase activity using
the Luciferase Reporter Assay Kit (Roche, NSW, Australia)
following the manufacturer’s instructions. Firefly luciferase
activity was normalized by the Gaussia luciferase readings
and the CAGA luciferase reporter activity per cell was cal-
culated. The number of cells which migrated was calcu-
lated by using the cell number in the 96 well plate and the
Gaussia luciferase readings using the following calculation:
Number of cells transferred through transwell = gaussia
reading of bottom chamber × cell number/gaussia reading
of 96 well plate.
Time lapse experiment
Cells were infected with or without Ad.pCAGA-td-to-
mato virus at a MOI of 2500 and seeded on to a 6 well
tissue culture plate at 20% confluency and stimulated
with or without TGF-β (5 ng/ml). 24 h later, cells were
imaged every 4 min for 10 h under 10x objective at 37°C
and 5% CO2 (Nikon eclipse Ti-E). The images were
analyzed using Metamorph software version 7.7.9.0
(Molecular divisions, USA) to calculate the distance that
the cells moved. The cells were tracked for up to 10 h
Luwor et al. Molecular Cancer  (2015) 14:50 Page 7 of 8(600 min) to calculate the distance (μm) moved. The
cells with Smad3 driven tomato expression were di-
vided into low red, medium red and high red groups
according to the intensity of their CAGA tomato reporter
activity.Statistical analysis
All statistical analysis performed using a two-tail students’
T-Test (p < 0.05 indicating a statistical significance).Additional files
Additional file 1: Figure S1. Smad3-Td-Tomato fluorescence is
proportional to the Smad2/3 Activity. MDA-MB-231 cells were infected
with Ad.CAGA-Td-Tom virus and A, B. stimulated with ± TGF-β (0-10 ng/ml)
or C. TGF-β (5 ng/ml) for various time point. Cells were fixed, permeabilised
and stained with DAPI, nuclear staining (blue). The relative pixel intensity of
Smad3 activity (Tomato fluorescence, red) was quantified (Average of 5
randomly chosen fields ± SD). These data are representative of at least 3
separate experiments (*P < 0.05). D. MDA-MB-231 cells were infected with
Ad.CAGA-Td-Tom virus and stimulated with ± TGF-β (5 ng/ml). Cells were
then fixed, permeabilised and stained for Smad2 expression and visualized
with Alexa488-conjugated secondary antibody (green) and td-Tomato
expression using confocal microscopy.
Additional file 2: Figure S2. MDA-MB-231 cells were infected with
Ad.pCAGA-td-tomato adenovirus at the multiplicity of infections (MOI)
indicated and stimulated with or without TGFβ1 (5 ng/ml). Cells were
then fixed, permeabilised and stained with DAPI. Percentage positivity
was calculated by visualizing Tomato expression (red) compared to total
cells (blue).
Additional file 3: Figure S3. Single Cell TGF-β Smad3 Activity in
U87MG cells Promotes Wound Healing. A. U87MG cells were infected
with Ad.CMV-Td-Tom at varying MOI or B. Ad.CAGA-Td-Tom virus at a
MOI of 2500. Following stimulation with ± TGF-β (5 ng/ml) for 24 h, cells
were fixed, permeabilised and stained with DAPI. Percentage positivity
was calculated by visualising Tomato expression (Red) compared to
nuclear staining (blue). C. 24 h post wound, U87MG cells were fixed,
permeabilised and nuclear stained as above and images were taken
visualizing Smad3 active cells (red) and nuclear staining (blue).Abbreviations
TGF-β: Transforming growth factor-beta; ATCC: American type tissue
collection; MOI: Multiplicity of infection; Ad: Adenovirus; Fluc: Firefly
luciferase; Gluc: Gaussia luciferase; DMEM: Dulbecco’s modified Eagle's
medium; FBS: Foetal bovine serum.
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